Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the Europ
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Haematologica, Volume 104, Issue 4 by Haematologica - Issuu
Sickle cell disease is a global prototype for integrative research and healthcare - Royal - 2021 - Advanced Genetics - Wiley Online Library
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
Haematologica, Volume 106, Issue 2 by Haematologica - Issuu
Haematologica, Volume 105, Issue 10 by Haematologica - Issuu
Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsiv
PDF) Pregnancy outcome in patients with -thalassemia intermedia at two tertiary care centers, in Beirut and Milan | Mohammed Naja - Academia.edu
![PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model](https://i1.rgstatic.net/publication/309957914_Hemolytic_anemia_repressed_hepcidin_level_without_hepatocyte_iron_overload_Lesson_from_Gunther_disease_model/links/5e1ee05692851c3cbe657577/largepreview.png "PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model")
PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model
Untitled
Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
Recommendations regarding splenectomy in hereditary hemolytic anemias | Haematologica
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Untitled
Vol. 102 No. 8 (2017): August, 2017 | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Haematologica, Volume 106, Issue 9 by Haematologica - Issuu
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients | Haematologica
Haematologica, Volume 102, issue 12 by Haematologica - Issuu
